Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis

Arthritis and Rheumatism

Volumn 60, Issue 5, 2009, Pages 1317-1323

  Maksymowych, W P ^a   Inman, R D ^b   Gladman, D D ^b   Reeve, J P ^a   Pope, A ^c   Rahman, P ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 7; PROTEIN ARTS1; PROTEIN TAP2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; ARTS1 GENE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ERAP1 GENE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINOPEPTIDASES; ATP-BINDING CASSETTE TRANSPORTERS; CANADA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MULTIENZYME COMPLEXES; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 66049103503     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24467     Document Type: Article

References (42)

1. Robinson WP, van der Linden SM, Khan MA, Rentsch HU, Cats A, Russell A, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27 patients. Arthritis Rheum 1989;32:1135-1141
2. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998;41:460-465
3. Zhu X, Wang Y, Sun L, Song Y, Sun F, Tang L, et al. A novel gene variation of TNFα associated with ankylosing spondylitis: a reconfirmed study. Ann Rheum Dis 2007;66:1419-1422
4. Maksymowych WP, Wessler A, Schmitt-Egenolf M, Suarez-Almazor M, Ritzel G, Von Borstel RC, et al. Polymorphism in an HLA-linked proteasome gene influences phenotypic expression of disease in HLA-B27 individuals. J Rheumatol 1994;21:665-669
5. Maksymowych WP, Jhangri GS, Gorodezky C, Luong M, Wong C, Burgos-Vargas R, et al. The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis 1997;56:448-454
6. Burney RO, Pile KD, Gibson K, Calin A, Kennedy LG, Sinnott PJ, et al. Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994;53:58-60.
7. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-1828.
8. Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000;59:883-886
9. McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 2001;40:1359-1364 (Pubitemid 33749024)
10. Timms AE, Crane AM, Sims AM, Cordell HJ, Bradbury LA, Abbott A, et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004;75:587-595
11. Maksymowych WP, Rahman P, Reeve JP, Gladman DD, Peddle L, Inman RD. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum 2006;54:974-985
12. Sims AM, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou CT, Doan T, et al. International genetics of ankylosing spondylitis: prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008;67:1305-1309
13. Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008;58:1020-1025
14. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-1337
15. Brown MA, Edwards S, Hoyle E, Campbell S, Laval S, Daly AK, et al. Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 2000;9:1563-1566
16. Tsui FW, Tsui HW, Cheng EY, Stone M, Payne U, Reveille JD, et al. Novel genetic markers in the 5′-flanking region of ANKH are associated with ankylosing spondylitis. Arthritis Rheum 2003;48:791-797
17. Chang SC, Momburg F, Bhutani N, Goldberg AL. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proc Natl Acad Sci U S A 2005;102:17107-17112
18. Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002;110:515-526
19. Gromme M, Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol 2002;39:181-202.
20. Van Kaer L. Major histocompatibility complex class I-restricted antigen processing and presentation. Tissue Antigens 2002;60:1-9. (Pubitemid 35177018)
21. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002;3:1177-1184
22. Hammer GE, Gonzalez F, Champsaur M, Cado D, Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2006;7:103-112 (Pubitemid 41823874)
23. Yan J, Parekh VV, Mendez-Fernandez Y, Olivares-Villagomez D, Dragovic S, Hill T, et al. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 2006;203:647-659
24. Fowler NL, Frazer IH. Mutations in TAP genes are common in cervical carcinomas. Gynecol Oncol 2004;92:914-921 (Pubitemid 38251396)
25. Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL, McGovern RM, et al. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 2003;88:326-332
26. Mehta AM, Jordanova ES, van Wezel T, Uh HW, Corver WE, Kwappenberg KMC, et al. Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes Chromosomes Cancer 2007;46:577-586
27. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-368 (Pubitemid 14134775)
28. Service S, DeYoung J, Pretorious H, Roos JL, Karayiorgou M, Bedoya G, et al. Extent, distribution and magnitude of linkage disequilibrium in eleven population isolates. Nat Genet 2006;38:556-560
29. Wigginton J, Abecasis G. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005;21:3445-3447 (Pubitemid 41222458)
30. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-121 (Pubitemid 37064867)
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188 (Pubitemid 17189972)
32. Purcell S, Sham P. WHAP: SNP haplotype analysis package. URL: http://pngu.mgh.harvard.edu/purcell/plink.
33. Sham PC, Rijsdijk FV, Knight J, Makoff A, North B, Curtis D. Haplotype association analysis of discrete and continuous traits using mixture of regression models. Behav Genet 2004;34:207-214 (Pubitemid 38268936)
34. Clayton D. SNPHAP: a program for estimating frequencies of large haplotypes of SNPs. URL: http://www-gene.cimr.cam.ac.uk/clayton/software/.
35. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K. Characterization of multilocus linkage disequilibrium. Genet Epidemiol 2005;28:193-206. (Pubitemid 40404574)
36. Becker T, Knapp M. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 2004;75:561-570 (Pubitemid 39244771)
37. Becker T, Cichon S, Jonson E, Knapp M. Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet 2005;69:747-756 (Pubitemid 41556327)
38. Becker T, Schumacher J, Cichon S, Baur MP, Knapp M. Haplotype interaction analysis of unlinked regions. Genet Epidemiol 2005;29:313-322 (Pubitemid 41720950)
39. Uddin M, Maksymowych W, Inman R, Gladman D, Sturge M, Peddle L, et al. Marked differences in genetic structure of two geographically distinct Canadian populations [abstract]. J Rheumatol 2008;35:1192.
40. Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, et al. An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 2002;3:1169-1176
41. Ciu X, Rouhani FN, Hawari F, Levine SJ. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 2003;278:28677-28685 (Pubitemid 36935774)
42. Cui X, Rouhani FN, Hawari F, Levine SJ. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003;171:6814-6819 (Pubitemid 37532116)